Xencor   Report issue

For profit Phase 1 Phase 2
Founded: Monrovia CA United States (1997)

Organization Overview

First Clinical Trial
2007
NCT00606645
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Vice President, Clinical Development, Xencor | VP, Oncology Clinical Development, Xencor | VP, Oncology Clinical Development, Xencor, Inc. | Xencor, Inc.